Thus, the combined use of techniques that investigate the methylation status, such as MS-MLPA and TP-PCR-based assay capable of assessing the number of CGG repeats in the FMR1 promoter, is, in our opinion, useful to fully describe the genetic defects in this region responsible for FXS. Here, FMR1 is linked to fragile X syndrome.